PNV 2.16% $2.36 polynovo limited

A Paradigm Shift in Practice-The Benefits of Early Active Wound Temporisation, page-23

  1. 4,211 Posts.
    lightbulb Created with Sketch. 309
    Gee, I thought I posted some real and interesting facts, you know, real sales figures (last 4q $4.5m, $4.6m, $3.9m), competitor history, unlike the PNV religion believers who constantly up-ramp the future prospects way out of proportion.

    Did you know the BTM was fda approved more than 4 years ago?
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.